ESC Premium Access

Basic mechanisms in pulmonary hypertension

Event: ESC CONGRESS 2016
Topic: Chronic pulmonary hypertension
Session type: Moderated Posters
Date: 29 August 2016
Time: 10:05 - 10:55


7 presentations in this session

A new experimental model of pulmonary arterial hypertension- KDR knock out

Speaker: Doctor M. Winter (Vienna, AT)

Hypoxia induces the downregulation of the BMP signalling in pulmonary artery smooth muscle cells through the endothelin system

Speaker: Doctor H. Maruyama (Tsuchiura, JP)

Preventive effects of novel urotensin II receptor antagonist in experimental pulmonary arterial hypertension

Speaker: Doctor B. Lee (Daejeon, KR)

Hemodynamic and anti-remodelling effect of the rho kinase inhibitor y-27632 in monocrotaline pulmonary arterial hypertension rat model

Speaker: Doctor S. Cantoni (Parma, IT)

Hypoxia-induced pulmonary hypertension is attenuated by hypoxia-inducible factor-1 alpha deletion in macrophage

Speaker: Mr H. Kojima (Fukuoka, JP)

Levosimendan prevents and reverts pressure-overload induced right ventricular failure.

Speaker: Miss M. Hansen (Aarhus, DK)

Inhibition of nuclear factor-kappaB-mediated inflammation improves RV function in rats with pulmonary artery banding

Speaker: Doctor K. Yoshida (Iizuka, JP)

7 speakers from this session

Doctor Max-Paul Winter

Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna (Austria)
0 follower

Doctor Hidekazu Maruyama

National Hospital Organization Kasumigaura Medical Center, Tsuchiura (Japan)
0 follower

Doctor Byung Ho Lee

Korea Research Institute Of Chemical Technology, Daejeon (Korea (Republic of))
0 follower

Doctor Silvia Cantoni

Chiesi Farmaceutici S.p.A., Parma (Italy)
0 follower

Mr Hiroshi Kojima

Kyushu University Graduate School of Medical Sciences, Fukuoka (Japan)
0 follower

Miss Mona Sahlholdt Hansen

Aarhus University Hospital, Aarhus (Denmark)
0 follower

Doctor Keimei Yoshida

Aso Iizuka Hospital, Iizuka (Japan)
0 follower

This platform is supported by

logo Novo Nordisk